IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Top Cited Papers
Open Access
- 17 January 2005
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 201 (2) , 233-240
- https://doi.org/10.1084/jem.20041257
Abstract
Interleukin (IL)-23 is a heterodimeric cytokine composed of a unique p19 subunit, and a common p40 subunit shared with IL-12. IL-12 is important for the development of T helper (Th)1 cells that are essential for host defense and tumor suppression. In contrast, IL-23 does not promote the development of interferon-γ–producing Th1 cells, but is one of the essential factors required for the expansion of a pathogenic CD4+ T cell population, which is characterized by the production of IL-17, IL-17F, IL-6, and tumor necrosis factor. Gene expression analysis of IL-23–driven autoreactive T cells identified a unique expression pattern of proinflammatory cytokines and other novel factors, distinguishing them from IL-12–driven T cells. Using passive transfer studies, we confirm that these IL-23–dependent CD4+ T cells are highly pathogenic and essential for the establishment of organ-specific inflammation associated with central nervous system autoimmunity.Keywords
This publication has 39 references indexed in Scilit:
- Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune InflammationThe Journal of Experimental Medicine, 2003
- Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic CellsScience, 2003
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17Journal of Biological Chemistry, 2003
- Distinct lineages of TH1 cells have differential capacities for memory cell generation in vivoNature Immunology, 2002
- Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosisMultiple Sclerosis Journal, 1999
- Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.The Journal of Experimental Medicine, 1995
- Migration of Hematogenous Cells Through the Blood‐Brain Barrier and the Initiation of CNS InflammationBrain Pathology, 1991
- Extracellular matrix receptors, ECMRII and ECMRI, for collagen and fibronectin correspond to VLA‐2 and VLA‐3 in the VLA family of heterodimersJournal of Cellular Biochemistry, 1988
- EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERONPublished by Elsevier ,1987